XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statement of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash Flows from Operating Activities    
Net loss $ (10,412,582) $ (5,755,256)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 827,696 247,366
Stock based compensation, including amortization of deferred equity compensation 742,729 564,667
Amortization of original issue discount and debt discount on convertible notes 530,930
Loss on sales of marketable securities 282,107
Change in fair value of derivative financial instruments (739,485)
Loss on extinguishment of debt 4,957,168 1,347,371
Change in fair value of debt 19,246 381,835
Change in fair value of contingent acquisition consideration 373,656 (75,952)
Changes in operating assets and liabilities:    
Accounts receivable 866 86,295
Inventory (39,730) (24,740)
Prepaid expenses and deposits (48,060) 73,125
ROU lease assets 109,587 222,781
Accounts payable and accrued expenses (169,589) 983,904
Lease liability (114,254) (221,009)
Due to related party, current portion 46,370
Contract liabilities (16,587) (67,606)
Net cash used in operating activities (3,769,854) (2,117,297)
Cash Flows from Investing Activities    
Proceeds from sale of marketable securities 2,784,782
Acquisition, net of cash acquired (810,156)
Payment of contingent acquisition consideration (322,106) (137,390)
Acquisition of property and equipment (19,250) (24,997)
Net cash (used in) provided by investing activities (341,356) 1,812,239
Cash Flows from Financing Activities    
Proceeds from sale of common stock 6,949,281 1,187,286
Proceeds from exercise of options and warrants 350,200
Proceeds from issuance of convertible notes 827,500
Repayment of convertible notes (1,882,405)
Proceeds from related party loans 149,000
Repayment of related party loans (967,756)
Proceeds from government loans 1,071,069
Repayment of vendor loans payable (51,109) (27,893)
Repurchase of treasury stock (7,700)
Net cash provided by financing activities 7,240,672 356,801
Net increase in cash 3,129,462 51,743
Cash, beginning of year 162,184 110,441
Cash, end of year 3,291,646 162,184
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest 232 203,396
Cash paid during the period for income tax
Schedule of non-cash investing and financing activities:    
Forgiveness of government loans 632,826
Common stock issuable issued during period 262,273 66,161
Fair value of warrants issued for professional service 43,236
Incremental fair value of warrants modified to extend maturity date of convertible notes payable 126,502
Conversion of convertible note payable to common shares 4,061,549 1,665,516
Fair value of warrants issued in connection with conversion of convertible notes payable 3,074,637
Accrued liabilities relieved upon cashless exercise of warrants 614,221
Contingent acquisition consideration payable in common stock 366,300
Fair value of liability-classified equity instruments issued 165,000
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable 211,497
Adoption of lease obligation and ROU asset 365,563
Fair value of shares issued as acquisition consideration 2,906,145
Fair value of contingent acquisition consideration issued 1,999,676
Derivative liabilities written off with repayment of convertible notes payable 328,000
Derivative liabilities written off with conversion of convertible notes payable 135,300
Reduction in contingent acquisition consideration 200,328
Fair value of marketable securities received as consideration for sale of common and preferred shares 3,006,889
Gain on extinguishment of related party debt allocated to additional paid in capital $ 283,862